Celator Pharmaceuticals Announces Pricing Of A $12.9M Public Offering Of … – Benzinga

Celator Pharmaceuticals Announces Pricing Of A $12.9M Public Offering Of
Benzinga
Celator Pharmaceuticals, Inc. (Nasdaq:CPXX), a pharmaceutical company developing new and more effective therapies to treat cancer, today announced the pricing of an underwritten public offering of 6,611,150 shares of common stock and warrants to …

and more

…read more

About The Author

error: Content is protected !!